Alnylam Pharmaceuticals | ALNY - Equity Capital And Reserves


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals reported $-259240000 in Equity Capital and Reserves for its fiscal quarter ending in March of 2023.


Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US USD 374.26M 26.15M
Agios Pharmaceuticals AGIO:US USD 1.04B 64.29M
Alnylam Pharmaceuticals ALNY:US USD -259240000 101.02M
Amgen AMGN:US USD 5.35B 1.69B
Arrowhead Research ARWR:US USD 446.77M 69.73M
Avrobio Inc AVRO:US USD 53M 22.37M
BioCryst Pharmaceuticals BCRX:US USD -328287000 33.69M
BioMarin Pharmaceutical BMRN:US USD 4.66B 55.89M
Bluebird Bio BLUE:US USD 354.74M 158.4M
Incyte Corp INCY:US USD 4.46B 92.45M
Intercept Pharmaceuticals ICPT:US USD 67.18M 25.89M
Ionis Pharmaceuticals IONS:US USD 486.57M 86.32M
Mirati Therapeutics MRTX:US USD 862.63M 133.89M
Moderna Inc MRNA:US USD 18.86B 260M
Neurocrine Biosciences NBIX:US USD 1.68B 23.3M
Novartis NVS:US USD 52.06B 7.28B
PTC Therapeutics PTCT:US USD -457561000 110.48M
Regeneron Pharmaceuticals REGN:US USD 23.5B 831.2M
Regulus Therapeutics RGLS:US USD 26.6M 6.7M
Sangamo BioSciences SGMO:US USD 335.61M 40.65M
Sarepta Therapeutics SRPT:US USD 712.75M 327.8M
Takeda 4502:JP JPY 6.35T 178.14B
Ultragenyx Pharmaceutical RARE:US USD 220.48M 132.01M
Vertex Pharmaceuticals VRTX:US USD 14.43B 519.6M
Xencor XNCR:US USD 683.58M 43.91M